Psoriasis Abstract
I-Psoriasis sisifo esixhaphakileyo se-T-cell-mediated immune disorder esibonakaliswa ngamacwecwe asokiweyo, abomvu, ajiyile anomlinganiselo ogqithisileyo wesilivere-mhlophe. Kwenzeka kwihlabathi jikelele, nangona iziganeko zisezantsi kwiindawo ezifudumeleyo, ezinelanga. Unobangela ophambili we-psoriasis awaziwa. Ngexesha lesi sifo esisebenzayo, inkqubo yokuvuvukala ephantsi ihlala ibandakanyeka. Uninzi lwezonyango eziqhelekileyo zijolise ekucinezeleni iimpawu ezinxulumene ne-psoriasis kwaye zineziphumo ezibi ezibalulekileyo. Eli nqaku liphonononga uninzi lweendlela eziphandiweyo zendalo kunyango lwe-psoriasis, ngelixa lijongana nonobangela walo. (Altern Med Rev 2007;12(4):319-330)
intshayelelo
Inkqubela phambili yamva nje yemfuza kunye ne-immunological iye yandisa kakhulu ukuqonda kwe-pathogenesis ye-psoriasis njengesifo esingapheliyo, esibangelwa yi-immune-mediated disorder disorder. Isiphako sokuqala somzimba kwi-psoriasis sibonakala sinyuka kwi-cell signing nge-chemokines kunye ne-cytokines esebenza kwi-gene expression ephakanyisiweyo kwaye ibangele i-hyper-proliferation ye-keratinocytes. Ukuqonda okutsha kwesi sifo sintsokothileyo kubangele uphuhliso lonyango lwebhayoloji ekujoliswe kulo. Olu nyango lwenguquko alukho ngaphandle komngcipheko onokwenzeka, nangona kunjalo. Uphononongo lolunye unyango lwendalo lubonelela ngeendlela ezithile zokwandisa ukhuseleko kunye nokusebenza kakuhle kulawulo lwe-psoriasis. I-Psoriasis � I-Pathophysiology, iSiqhelo, kunye neendlela ezizezinye zoNyango uMichael Traub, ND, kunye noKeri Marshall MS, ND
Epidemiology
Ukuxhaphaka kwe-psoriasis kuyahluka ngokubanzi ngokuxhomekeke kubuhlanga. I-Psoriasis ixhaphake kakhulu kwiCaucasus, kunye neemeko eziqikelelwayo ze-60 kwi-100,000 / ngonyaka kule ndawo. Ukuxhaphaka kwayo e-United States yi-2-4 yeepesenti, nangona inqabile okanye ingekho kwi-Native American kunye nabemi abathile base-Afrika-baseMelika. Nangona ixhaphakile eJapan, ayixhaphakanga kangako eTshayina, kuqikelelwa ukuba kukho i-0.3 ekhulwini. Ukuxhaphaka kwabemi ngokubanzi kuMntla Yurophu kunye neScandinavia yi-1.5-3 ekhulwini. Abasetyhini kunye namadoda bachaphazeleka ngokulinganayo kule meko. Ukuqwalasela ukuba i-latitude ichaphazela ukuxhaphaka kunokwenzeka ukuba inxulumene nomphumo onenzuzo wokukhanya kwelanga kwisifo.1 Nangona i-psoriasis ingenzeka nakweyiphi na iminyaka, iminyaka yobudala bokuqala kwi-plaque engapheliyo iqikelelwa kwiminyaka eyi-33, kunye neepesenti ze-75 zamatyala aqaliswe. phambi kweminyaka yobudala engama-46.2 Iminyaka yobudala ibonakala ihamba kancinci kwabasetyhini kunamadoda. Uphononongo lwexesha elide lubonisa ukuxolelwa ngokuzenzekelayo kunokwenzeka malunga nesinye kwisithathu sezigulane ezine-psoriasis.3
Pathophysiology
Kuze kube kutshanje i-psoriasis yayithathwa njengengxaki ye-epidermal keratinocytes; nangona kunjalo, ngoku yaziwa ngokuyintloko njengengxaki yokukhusela umzimba. Ukuze uqonde kakuhle ukungasebenzi kakuhle kwamajoni omzimba okukhoyo kwi-psoriasis, kunyanzelekile ukuba uqonde impendulo eqhelekileyo yolusu. Ulusu lilungu eliphambili le-lymphoid elinenkqubo esebenzayo yokujonga i-immunology exhotyiswe ngeeseli ezibonisa i-antigen, i-cytokine synthesizing keratinocytes, iiseli ze-epidermotropic T, iiseli ze-dermal capillary endothelial, i-draining nodes, iiseli zemast, i-tissue macrophages, i-granulocytes, i-fibroLanger, iiseli ze-fibroblasts, iiseli ze-fibroblasts kunye neeseli ze-fibroblasts. Ulusu lukwanalo ne-lymph nodes kunye ne-T lymphocytes ejikelezayo. Xa zidibene ezi seli zinxibelelana nge-cytokine secretion kwaye ziphendule ngokufanelekileyo ngokuvuselelwa yibhaktheriya, iikhemikhali, ukukhanya kwe-ultraviolet (UV) kunye nezinye izinto ezicaphukisayo. I-cytokine ephambili ekhutshwe ekuphenduleni umboniso we-antigen yi-tumor necrosis factor-alpha (TNF-?). Ngokuqhelekileyo, le yinkqubo elawulwayo ngaphandle kokuba ukuhlambalaza kwesikhumba kuthatha ixesha elide, apho ukuveliswa kokungalingani kwe-cytokine kukhokelela kwimeko ye-pathological efana ne-psoriasis.
Ingxoxo iyaqhubeka nokuba ngaba i-psoriasis yi-autoimmune disorder okanye i-T-helper 1 (Th1) i-immune dysfunction. I-T-cell activation, i-TNF-?, kunye neeseli ze-dendritic zizinto ze-pathogenic ezivuselelwe ekuphenduleni into ebangela ukuba ibangele, njengokulimala komzimba, ukuvuvukala, ibhaktheriya, intsholongwane, okanye ukuhoxiswa kwamayeza e-corticosteroid. Ekuqaleni, iiseli ze-dendritic ezingekabikho kwi-epidermis zivuselela iiseli ze-T ezivela kwi-lymph nodes ekuphenduleni ukuvuselelwa kwe-antigen engaziwa. I-lymphocytic ingena kwi-psoriasis ikakhulu i-CD4 kunye neeseli ze-CD8 T. Iimolekyuli zokubambelela ezikhuthaza ukunamathela kwe-leukocyte zibonakaliswe kakhulu kwizilonda ze-psoriatic.4 Emva kokuba iiseli ze-T zifumana ukuvuselela okuphambili kunye nokusebenza, ukuveliswa kwe-mRNA ye-interleukin-2 (IL-2) kwenzeka, okubangelwa ukwanda okulandelayo kwe-IL-2 receptors. I-Psoriasis ithathwa njengesifo se-Th1 ngenxa yokwanda kwee-cytokines zendlela ye-Th1 � interferon gamma (IFN-?), IL-2, kunye ne-interleukin 12 (IL-12) � efumaneka kwiiplagi ze-psoriatic.
Ukonyuka kwe-IL-2 ukusuka kwiiseli ze-T ezisebenzayo kunye ne-IL-12 kwiiseli zeLangerhans ekugqibeleni zilawula iijene zekhowudi yokubhalwa kwee-cytokines ezifana ne-IFN-?, TNF-?, kunye ne-IL-2, ejongene nokwahlula, ukuvuthwa, kunye nokwanda kwe T iiseli kwimemori effector cells. Ekugqibeleni, iiseli ze-T zifudukela eluswini, apho ziqokelelana kufutshane nemithambo yegazi yedermal. Ezi ziyokuqala kuluhlu lweenguqu ze-immunologic ezibangela ukubunjwa kwezilonda ezibukhali ze-psoriatic. Ngenxa yokuba impendulo ye-immune echazwe ngasentla iyimpendulo ethile eqhelekileyo ekuvuseleleni i-antigen, ihlala ingacacanga ukuba kutheni i-T-cell activation eyenzekayo, ilandelwa yimfuduko elandelayo ye-leukocytes kwi-epidermis kunye ne-dermis, idala ukwanda kweselula ngokukhawuleza. Ukulawulwa kwemfuza okusemgangathweni kunokuba ngunobangela. I-Vascular endothelial growth factor (VEGF) kunye ne-interleukin-8 ekhutshwe kwi-keratinocytes inokufaka isandla kwi-vascularization ebonwe kwi-psoriasis.5
Iiseli ze-dendritic zibonakala zibandakanyeka kwi-pathogenesis ye-psoriasis. Olunye uhlobo lweeseli ze-dendritic ezibandakanyekayo ziiseli zeLangerhans, oyena mlindi wenkqubo yokhuselo lomzimba ebonayo kwaye ibambe ii-antigens, ifudukele kwii-lymph nodes zalapha, ize izinikeze kwiiseli ze-T. Ukusetyenziswa kwe-T lymphocytes kukhulula i-cytokines e-pro-inflammatory efana ne-TNF-? oku kukhokelela ekwandeni kwekeratinocyte. Le mpendulo ye-hyperproliferative iyancipha ixesha lokuhamba kwe-epidermal (ixesha elichanekileyo elithathayo ukuvuthwa okuqhelekileyo kweeseli zesikhumba) ukusuka kwiintsuku ze-28 ukuya kwiintsuku ze-2-4 kwaye ivelise i-scaly plaques ye-psoriasis ye-erythematous. Oku kuqonda kweendlela ze-pathogenic kuye kwakhokelela ekuphuhlisweni kunye nokusetyenziswa kwezonyango kwe-TNF-? i-blocking agents.
Malunga neepesenti ezingama-30 zabantu abane-psoriasis banembali yosapho yesi sifo kwisihlobo sokuqala okanye sesibini. Ubuncinci iiloci ezisithoba zokuchaphazeleka kwekhromosomal ziye zacaciswa (PSORS1-9). I-HLA-Cw6 yeyona nto iphambili kwi-phenotypic expression. Umbutho kunye ne-PSORS ifunyenwe kunye ne-polymorphisms esebenzayo kwi-modifier genes eyenza ukuvuvukala (umzekelo, i-TNF-?) kunye nokukhula kwe-vascular (umzekelo, i-VEGF) .6
Kuyaziwa ukuba i-psoriasis ikhula kwi-bone marrow abamkeli abasuka kubaxhasi abane-psoriasis, icoca kubamkeli kubaxhasi ngaphandle kwe-psoriasis, kwaye iziyobisi ze-immunosuppressive ziyasebenza ekunciphiseni i-psoriasis.7,8 Ngenxa yofuzo lwesi sifo, yintoni enokwenziwa ukuze ukunciphisa ukubonakaliswa kwemfuza ngaphandle kokubhenela kunyango lwe-immunosuppressive? Indlela ye-naturopathic ibandakanya ukuguqulwa kokutya,�ukuzila ukutya, ukongezwa kwe-omega-3, amayeza endalo endalo, amayeza esintu, kunye nolawulo loxinzelelo.
UPizzorno noMurray bacebisa ukuba ezi zikhankanywe ngasentla �ii-antigens ezingachazwanga� ziphuma kwiprotein engaphelelanga, ukunyuka kwamathumbu emathunjini, kunye nokutya okutyayo; isilonda i-toxemia (i-endotoxins); ukukhutshwa kwesibindi okungasebenzi kakuhle; ukusilela kwe-bile acid; ukusetyenziswa kotywala; ukusetyenziswa ngokugqithiseleyo kwamafutha ezilwanyana; ukusilela kwezondlo (iivithamini A kunye ne-E, i-zinc, kunye ne-selenium); kunye noxinzelelo.9 Ezi ngcamango, nangona zikholeleka, azizange zivavanywe ngokwaneleyo.
I-Co-Morbidities
I-Psoriasis inxulunyaniswa ne-co-morbidities ezininzi, kubandakanya ukuhla komgangatho wobomi, ukudakumba, ukwanda komngcipheko we-cardiovascular, uhlobo lwe-2 yeswekile, isifo se-metabolic, umhlaza, isifo sikaCrohn, kunye nesifo samathambo. Kuhlala kungacacanga ukuba umhlaza, ngakumbi umhlaza wolusu kunye ne-lymphoma, zinxulumene ne-psoriasis okanye kunyango lwayo. I-Phototherapy kunye ne-immunosuppressive therapy inokunyusa umngcipheko we-non-melanoma yomhlaza wesikhumba, umzekelo.10
Eyona nto ixhalabisayo likhonkco elijongwayo phakathi kwe-psoriasis kunye nesifo senhliziyo. Ubungqina bubonisa ukuba i-psoriasis yinto ezimeleyo yengozi yesifo se-cardiovascular disease.11 Dyslipidemia, i-coronary calcification, i-protein ye-C-reactive (CRP), iyancipha i-folate, kunye ne-hyperhomocysteinemia ifumaneka ngokuphindaphindiweyo kwizigulane ze-psoriasis.12 Ukuvuvukala ngumxholo oqhelekileyo. phantsi kweemeko zombini, ezibonakaliswe kubukho be-cytokines e-pro-inflammatory kunye ne-activation endothelial.
Iinkqubo ezivuthayo eziphantsi kwe-psoriasis nazo ziphakamisa ukuba kunokwenzeka ukuba i-omega-3 fatty acid, i-folate, kunye ne-vitamin B12 ingabikho, ekwafumaneka rhoqo kwisifo senhliziyo. Isantya esikhawulezayo sokuguqulwa kweeseli zesikhumba kwi-psoriasis sinokubangela ukwanda kokusetyenziswa kwe-folate kunye nokusilela okulandelayo. folate kunye nezinto ezongezelelekileyo zengozi yentliziyo.�13
I-Psoriatic arthritis yimeko yeklinikhi eyenzeka kwiipesenti ze-25 zabantu abane-psoriasis. I-Psoriatic arthritis ihlala ibonakalisa njenge-seronegative arthritis yokukrala, kunye nomboniso weklasikhi obandakanya i-oligoarthritis, ukubandakanyeka kwe-distal interphalangeal joint, i-dactylitis (ukudumba kwamanani), kunye nokudumba kwe-calcaneal.
Iimbono ziphikisana nokuba imeko yesikhumba kunye ne-arthritis ibonisa ukubonakaliswa okwahlukileyo kwesifo esifanayo. Ubungqina be-Genetic, izifundo ze-immunological, kunye nokuguquguquka kwempendulo yonyango zicebisa ukuba zinokuba neemeko ezimbini ezahlukeneyo, mhlawumbi kunye nokuvuvukala okuphantsi okufanayo kunye nokungahambi kakuhle kwe-immune.17,18.
Nangona i-palmoplantar pustulosis (PP) idla ngokuchazwa njenge-subtype ye-psoriasis, i-demographics eyahlukeneyo kunye nohlalutyo lwezofuzo lubonisa i-etiology eyahlukileyo kune-psoriasis. Kwinkangeleko, i-PP ine-yellowbrown sterile pustules evela ezintendeni nasezintweni. Kuphela iipesenti ezingama-25 zalabo bachaphazelekayo babika i-plaque psoriasis engapheliyo. I-PP iyenzeka rhoqo kubasetyhini (i-9: 1 / ibhinqa: indoda) kunye neepesenti ze-95 zabantu abachaphazelekayo banembali yangoku okanye yangaphambili yokutshaya. Ngenxa yoko, i-PP inokuthathwa njengemeko ye-co-morbid kunokuba uhlobo oluhlukileyo lwe-psoriasis.19
Iimpawu zokuxilonga
I-Psoriasis ihlelwa ngokweendidi ezininzi, kunye ne-plaque engapheliyo (i-psoriasis vulgaris) ifomu equka malunga neepesenti ze-90 zamatyala. Iipleyiti ezibukhali ze-erythematous silvery scaling plaques zenzeka kakhulu kumphezulu we-elbows, amadolo, isikhumba, i-sacral kunye ne-groin. Eminye imimandla ebandakanyekayo ibandakanya iindlebe, i-glans penis, indawo yeperinaal, kunye neendawo zokwenzakala okuphindaphindiweyo. Imeko esebenzayo yokuvuvukala kwe-psoriasis ingabonisa i-Koebner phenomenon apho izilonda ezintsha zenza kwindawo yokulimala okanye uxinzelelo.
Kwixesha elizayo, i-Plaque Psoriasis engapheliyo inokufunyanwa ineemeko ezininzi ezinxulumeneyo kunye neempawu ezicacileyo ze-phenotypical kunye ne-genotypical, inika inkcazo yempendulo yayo eguquguqukayo kunyango, ngakumbi ngeearhente zebhayoloji.
I-psoriasis eguquguqukayo yenzeka kwiindawo ezidibeneyo kunye nokugotywa kwesikhumba kwaye ibomvu, iyabengezela, kwaye ihlala ingenasikali. I-Sebopsoriasis, edla ngokubhidaniswa ne-seborrheic dermatitis, ibonakala ngamaxolo anamafutha.kumashiya, i-nasolabial folds, kunye neendawo ze-postauricular kunye ne-presternal.
I-Acute guttate psoriasis ivela kubantwana, abafikisayo, kunye nabantu abadala abancinci malunga neeveki ezimbini emva kosulelo olubukhali lwe-beta-hemolytic streptococcal, olufana ne-tonsillitis okanye i-pharyngitis, okanye usulelo lwentsholongwane. Ibonakalisa njenge-erythematous, i-papular eruption kunye nezilonda ezingaphantsi kwe-1 cm ububanzi kwi-trunk kunye neziphelo. I-Acute guttate psoriasis idla ngokuzibekela umda, isonjululwe kwiinyanga ezi-3-4. Olunye uphando lubonise isinye kwisithathu kuphela sabantu abane-guttate psoriasis bahlakulela i-classic plaque psoriasis.20
I-Pustular psoriasis (von Zumbusch) ikwayi-acute psoriatic eruption. Isigulana sibonisa umkhuhlane kunye nencinci, i-monomorphic, ibuhlungu, i-pustules eyinyumba, ehlala iqhutywe yintsholongwane ye-intercurrent okanye ukuhoxiswa ngokukhawuleza kwe-systemic okanye i-superpotent topical steroids. Inokuthi ibekwe kwindawo yesundu kunye ne-soles (i-palmar-plantar psoriasis) okanye ingenziwa ngokubanzi kwaye inokubeka ubomi esichengeni.
I-Erythrodermic psoriasis, ekwasongela ubomi, ibandakanya yonke indawo yomzimba kwaye inokubangela i-hypothermia, i-hypoalbuminemia, i-anemia, usulelo, kunye nokungaphumeleli kwentliziyo ephezulu.
Isifo sezikhonkwane se-Psoriatic senzeke malunga neepesenti ze-50 zezigulane ze-psoriasis kwaye zidla ngokubonakala njenge-pitting. Olunye utshintsho lwezikhonkwane lungabandakanya i-onycholysis, i-discoloration, ukuqina, kunye ne-dystrophy.
Izinto zobungozi
Ukuphuhliswa kwe-psoriasis kubandakanya ukusebenzisana kwezinto ezininzi zomngcipheko wemfuza kunye nezinto ezisingqongileyo, ezifana ne-beta-hemolytic streptococcal infection, i-HIV, uxinzelelo, kunye namayeza (umzekelo, i-beta-blockers kunye ne-lithium). Njengoko bekutshiwo ngaphambili, ukunqongophala kwe-folate kunye ne-vitamin B12 nako kunokukhokelela. Ukongezelela, kukho ubungqina bokuba utywala, ukutshaya icuba, ukutyeba, uhlobo lwe-2 yeswekile, kunye nesifo se-metabolic kwandisa umngcipheko wokuphuhlisa i-psoriasis.
Ngaphandle kweVEGF, akukho biomarkers zifunyenwe njengeziqikelelo ezithembekileyo zomsebenzi we-psoriasis. I-CRP, i-adhesion molecules e-soluble, kunye ne-soluble cytokine receptors ziye zaphandwa kodwa azihambelani nobunzima.21
Unyango oluqhelekileyo
Unyango oluqhelekileyo lwe-psoriasis lusekelwe kwinqanaba lobunzima. Unyango lwe-psoriasis oluncinci kunye noluncinci lubandakanya i-corticosteroids ye-topical, i-tars, i-anthralin, i-calcipotriene (i-vitamin D3 analog), i-tazarotene (i-retinoid), kunye ne-phototherapy. Oogqirha banokubeka izinto ezilindelekileyo zonyango, ukunika isigulane ukulawula kwesi sifo ngaphandle kokulindela unyango olupheleleyo. I-scalp psoriasis idla ngokuphendula kwiishampu ze-salicylic acid.
I-UVB ekwi-Narrow-band ayisebenzi kangako kodwa ikhuselekile kune-psoralen kunye ne-ultraviolet A (PUVA), enomngcipheko owongeziweyo womhlaza wolusu. Ukutshatyalaliswa kwelanga lolunye uhlobo lwe-phototherapy. Ukubonakaliswa kwe-UV kunciphisa ukubonakaliswa kwe-antigen kwaye kuchaphazela ukubonakaliswa kweeseli, ukuthanda uphuhliso lwe-T-helper 2 (Th2) iimpendulo zomzimba. Iiseli zeLangerhans ezibonisa i-Antigen ziyancipha kuzo zombini inani kunye nomsebenzi.22
Inhlanganisela ye-calcipotriene kunye ne-betamethasone (i-Taclonex) ibonise ukuphumelela okukhulu kwi-psoriasis enzima kune-monotherapy kunye nokuba yodwa.23
Ukuthotyelwa kwesigulane kufuneka kuthathelwe ingqalelo xa kuphuhliswa isicwangciso sonyango. Ukusetyenziswa kwesisombululo esincinci se-topical kunye nokulungiswa kwe-foam ye-corticosteroids ye-topical kunye ne-calcipotriene (xa kuthelekiswa namafutha kunye nama-creams) kunokuphucula ukuthotyelwa.
Unyango olucwangcisiweyo lwe-psoriasis enzima lubandakanya ukusetyenziswa kwe-retinoids yomlomo, i-methotrexate, i-cyclosporine, kunye ne-biological agents ezinokuchaphazela kakhulu ezinye iinkqubo zomzimba.
I-retinoid acitretin yomlomo i-teratogenic kwaye iguqulwa ibe yi-etretinate kunye nokusela utywala obuhambelanayo. I-Etretinate inobomi obude kwaye ine-teratogenic ngaphezu kwe-acitretin. Izigulana ezingamabhinqa kufuneka zisebenzise iindlela ezimbini zolawulo-nzala kwaye akufuneki zikhulelwe ubuncinci iminyaka emithathu emva konyango. Ngenxa yokusebenzisana okunokwenzeka kunye nezithinteli zokukhulelwa ngomlomo, iSt. John's wort (Hypericum perfoliatum) kufuneka iphetshwe. Eminye imiphumo emibi ibandakanya imiphumo ye-mucocutaneous, i-triglycerides ephakamileyo, i-alopecia, kunye ne-hepatitis. Unyango nge-acitretin lufuna ukubekwa esweni rhoqo kobalo lwegazi, iiprofayili zemetabolism ezibanzi, kunye nohlalutyo lokuchama. Amaqhinga okunciphisa i-acitretin toxicity ibandakanya ukusetyenziswa kwe-intermittent, ukunciphisa umthamo wesondlo kuyo yonke enye imini okanye yonke imihla yesithathu, unyango oludibeneyo kunye ne-PUVA okanye i-calcipotriene ye-topical, ukutya okunamafutha aphantsi, ukuzivocavoca kwe-aerobic, ukongezwa kweoli yeentlanzi, kwaye njengoko kuchazwe ngasentla, ukuphepha utywala.
I-Methotrexate (i-MTX) yi-agent ye-systemic esetyenziswa ngokuqhelekileyo kwi-psoriasis kwaye, ngenxa yokuba ikhona iminyaka eyi-35, ininzi yedermatologists ikhululekile ngokusetyenziswa kwayo. I-Methotrexate inqanda i-dihydrofolate reductase (ebangela ukusilela kwe-folic acid esebenzayo) kwaye yenza i-adenosine A1, i-agonist enamandla yokulwa nokuvuvukala. Indlela yokusebenza kwayo inokuba nzima ngakumbi, ibonakaliswe kukuba i-caffeine inqanda i-MTX's anti-inflammatory effects kwi-rheumatoid arthritis kodwa kungekhona kwi-psoriasis okanye i-psoriatic arthritis.24 Iziphumo ezibi kakhulu eziqhelekileyo ze-MTX yi-myelosuppression kunye ne-fibrosis yesibindi. Nangona i-myelosuppression ingenzeki rhoqo, izigulane ezisebenzisa i-MTX zihlala zichaza iimpawu zentloko, ukukhathala, kunye nesicaphucaphu. Ukuxhaswa kwe-folate kunciphisa iziganeko ze-megaloblastic anemia, i-hepatotoxicity, kunye nokunyanzeliswa kwesisu. Nangona i-folic acid kunye ne-folinic acid zibonakala zisebenza ngokulinganayo, i-folic acid ixabisa ngakumbi. . Izigulane zabelwa ngokungaqhelekanga ukufumana i-25 mg / imini ye-folic acid okanye i-placebo kwiiveki ze-22. I-PASI ephakathi kwenyuka (imbi kakhulu) kwiqela le-folic acid, ukusuka kwi-5 kwisiseko ukuya kwi-12 kwiiveki ze-6.4. Kwiqela le-placebo, i-PASI ye-PASI yawa ukusuka kwi-10.8 kwisiseko ukuya kwi-12 kwiiveki ze-9.8 (p <9.2 ngenxa yokwahlukana kwenguqu phakathi kwamaqela) .12
I-Cyclosporine, ichiza elinamandla kunye netyhefu, ngamanye amaxesha liqwalaselwa kwiimeko ezingalawulwayo nge-acitretin, i-PUVA, okanye i-MTX, kodwa ichasene nezigulane ezinomsebenzi ongaqhelekanga wezintso, uxinzelelo lwegazi oluphantsi, ukungasebenzi kakuhle kwesibindi, okanye ukugonywa kwe-immunosuppression. Ukusetyenziswa ixesha elide ngokuqinisekileyo kubangela umonakalo wezintso. Uxinzelelo lwegazi kunye nokujongwa kwe-creatinine kubalulekile.
Ii-Biological agents zivimba ukusebenza kwe-T-cell kunye ne-TNF-? I-Alefacept (Amevive�) iphazamisa ukusebenza kwe-T-cell kwaye inciphisa ukujikeleza kweeseli ze-CD 45 RO+ T. Eli chiza liyiprotheni edibeneyo ye-Fc receptor ye-IgG1 yabantu kunye ne-LFA3, i-co-stimulatory ligand, esebenzisana ne-CD2 kumphezulu we-T-cell. Iiseli ze-CD4 kufuneka zibekwe esweni qho ngeveki ngexesha lonyango ngale arhente.
I-Efalizumab (i-Raptiva�) li-antibody eyenzelwe umntu kwi-CD11 ephazamisana nokurhweba nge-T-cell kwizicubu ezivuthayo kwaye inqanda ukusebenza kwe-T-cell. Nangona isebenza ngokukhawuleza, inokwenzeka kwakhona.
TNF-? i-blockers yehlisa i-proinflammatory gene expression kunye nokubuyisela umva i-phenotype ye-psoriatic. I-Etanercept (Enbrel�) yiprotheni edityanisiweyo ejoliswe ngokuchasene ne-TNF-? I-Infliximab (i-Remicade�) yi-mouse/i-chimeric yomntu i-monoclonal antibody ngokuchasene ne-TNF-? Ezi TNF-? i-inhibitors ilawulwa nge-injection kwaye idibaniswe nokungeniswa kwezinto ezahlukeneyo ze-autoimmune phenomena. Njenge TNF-? ngokwayo, TNF-? i-inhibitors ingaba nemisebenzi ye-proinflammatory kunye ne-anti-inflammatory. Kungenxa yokuba i-arhente ethile ivimbela i-TNF-?, ayincedi nge-psoriasis. Ukuba isigulane sine-genetically predisposed to overproducing TNF- ?, Ukuyinqanda akunakukwanela ukuvelisa inzuzo.27 Iingozi ezinokwenzeka ze-TNF-? izithinteli ziquka ukuvuselelwa kwesifo sephepha esifihlakeleyo, i-hepatotoxicity, i-lymphoma, kunye nokungaphumeleli kwentliziyo.
Imingeni eseleyo kwi-biologics ye-psoriasis ibandakanya: (1) ukuqonda eyona ndlela iphambili kwi-psoriasis kunye ne-psoriatic arthritis; (2) ukuqonda iimpendulo zezigulane ezahlukeneyo kunyango; (3) ukuxela kwangaphambili impendulo yeklinikhi ngaphambi okanye ekuqaleni kwonyango; (4) ukuphuhlisa imixube yomlomo, yokuphefumlelwa kunye neyezihloko; kunye (5) nokugqiba ukuba ngaba unyango luguqula umphumo wexesha elide.
I-Fumaric acid lolona nyango luphambili lwe-psoriasis eJamani. Inciphisa ii-cytokines ezixhomekeke kwi-T-cell, kodwa ayisebenzi njengolunye unyango oluqhelekileyo, kwaye inomngcipheko ophezulu wetyhefu kunye nokunganyangeki kwesisu.
Ukubonelela ngonyango olujikelezayo kunye nokudibanisa kwandisa ukusebenza kunye nokunciphisa ubutyhefu bonyango. Ikamva lisenokuzisa unyango lwe-stem-cell kunye nonyango olusekwe kumfuza, kubandakanywa nonyango lwe-antisense olunqanda ngokuthe ngqo uhlobo oluthile lwe-psoriasis. Nangona kunjalo, iziphumo ezibi kunye netyhefu yonyango oluqhelekileyo lwe-psoriasis lufuna unyango lwendalo olukhuselekileyo nolusebenzayo olunokuthi lusetyenziswe njengezinye iindlela okanye ngendlela edibeneyo.
Unyango lweNdalo Kuba Psoriasis
idayethi
Indlela esekelwe kubungqina ibonisa i-psoriasis, eyona nto i-disorder disorder, kufuneka izuze kwi-anti-inflammatory diet, ukuchonga, ukupheliswa kunye / okanye ukujikeleza kokutya kwe-allergenic, kunye nokuzila ukutya. , izigulane ezininzi ze-psoriasis zibonisa ukunyuka kwe-gluten kunye neempawu zabo ze-psoriasis ziphucula kwi-gluten-free diet.28 Umlinganiselo we-antibodies kwi-tissue transglutaminase kunye ne-gliadin inokunceda ukuchonga eli qela. Ubungqina buphinda bucebise ukugcina ubunzima obunempilo kwizigulane ze-psoriasis, ekubeni i-psoriasis ihambelana ngokufanelekileyo kunye nokwanda kwe-index mass body.30
Ulungelelwaniso phakathi kwe-eicosanoids ye-proinflammatory kunye ne-anti-inflammatory eicosanoids ichaphazeleka kakhulu luhlobo lwe-fatty acids edliwayo. Ukutya okuchasene nokudumba kukugxininisa kumafutha alungileyo (iintlanzi zamanzi abandayo, iindongomane, imbewu, ioli yomnquma, ezinye ioyile ezikumgangatho ophezulu), iinkozo ezipheleleyo, iimbotyi, imifuno, kunye neziqhamo kunye nokuphepha "amafutha amabi" (ahluthisiweyo). amafutha ezilwanyana, amafutha atshintshiweyo, ukutya okuqhotsiweyo kunye nokucutshungulwayo, i-oyile ekumgangatho ophantsi) kunye neecarbohydrates ezisulungekileyo. Ukongezelela, ubuninzi be-omega-6 fatty acids ekutyeni bunokuba negalelo kwimpendulo yokuvuvukala.33 Imithombo ephambili ye-omega-6 yokutya ioli yemifuno efana nengqolowa, i-soy, i-safflower, kunye ne-sunflower, ngelixa imithombo ephambili. ze arachidonic acid yinyama, amaqanda, kunye nobisi.
I-Prostaglandin E2 (PGE2) yi-eicosanoid evelele ephuma kwi-omega-6 fatty acid arachidonic acid. Isenzo esiphezulu se-PGE2 njenge-molecule yesithunywa kukuphucula ukuvakalelwa kwiintlungu ze-neurons, ukwandisa ukuvuvukala, kunye nokunciphisa imithwalo yegazi. Ukusetyenziswa ngokugqithiseleyo kweoli ye-omega-6 kunika i-substrate engaphezulu kwe-synthesis ye-PGE2, eqhuba impendulo enobudlova kunye neqhubekayo yokuvuvukala. I-Prostaglandin E3 (PGE3) yi�evela kwi-omega-3 fatty acid, i-eicosapentaenoic acid (EPA). Amanqanaba aphezulu e-PGE3 anciphisa uvakalelo kwiintlungu, ukukhulula imithambo yegazi, ukwandisa ukuhamba kwegazi, kunye nokuxhasa impendulo yomzimba yendalo yokuchasana nokudumba (Umfanekiso 1).
Ngelixa zombini i-PGE2 kunye ne-PGE3 ziyimfuneko kwi-homeostasis efanelekileyo, izixa ezihambelanayo zezi molekyuli zezithunywa ezikhuphisanayo zinokuba negalelo okanye zinciphise ii-syndromes ezingapheliyo ezivuthayo. I-EPA icingelwa ukuba isebenze ngokukhuphisana ne-arachidonic acid kwiindawo zokubopha kwi-cyclooxygenase-2 (COX-2), ukuvelisa umlamli ovuthayo ongenamandla, ngoko ke ukunciphisa ukuvuvukala.34
Ngaphambi kwe-Industrial Revolution, kwakungekho mithombo ebalulekileyo ye-omega-6 yeoli yemifuno ekutyeni. Uninzi lweenkcubeko zitya ukutya okuphantsi kwezi oyile kunye nentlanzi ephezulu okanye inyama yenkomo etyiswe kuluhlu okanye inyathi ephezulu kwi-omega-3s, idala umlinganiselo we-omega-6: i-omega-3 eyayimalunga ne-3: 1. I-Industrial Revolution yeza nolwazi kunye nezixhobo zokusulungekisa i-oyile yemifuno, okukhokelela ekutshintsheni ngokukhawuleza kwindlela yokutya kwiinkcubeko ezininzi zaseNtshona. Umlinganiselo we-omega-6: i-omega-3 yatyhalelwa ngokukhawuleza ukuya kuqikelelo lwangoku oluphezulu njenge-11: 1 i-omega-6: i-omega-3.35 Umzimba womntu awukwazanga ukuziqhelanisa nofuzo kolu tshintsho oluphawulekayo ekusebenziseni i-asidi enamafutha.
Iinkcubeko ezininzi zanamhlanje zisebenzisa izixa ezininzi zeoyile yemifuno, ubukhulu becala ekutyeni okucutshungulweyo. Ngokomzekelo, ukuveliswa kweoli ye-soy yokusetyenziswa kokutya kunyuke i-1,000-fold phakathi kwe-1909 kunye ne-1999.36 Ukongeza, imfuyo, iinkukhu, kunye neentlanzi ezifuywayo zondliwa i-cornmeal kunye ne-soy-based feed, ephakamisa umxholo we-omega-6 wenyama kunye nentlanzi. Xa izilwanyana zasefama ziphakanyiswe ngotshani, iintshulube, okanye ezinye izidlo zendalo, izicubu ziphezulu ngokwemvelo kwi-omega-3 fatty acids.37
Ishishini lenyama yenkomo lincoma �ukurhweba� kwimveliso yenkomo egqityiweyo, ngenxa yombona kunye nokutya kwesoya. Iinkomo ezityiswa umbona kunye nesoya zine-omega-6 fatty content ephezulu xa kuthelekiswa neenkomo ezondliwe ingca. Ngelixa iinkomo ezitya ingca zinokuqulatha ukuya kuthi ga kwi-4-pesenti ye-omega-3 fatty acids, iinkomo ezondliwa ngombona ziqukethe i-0.5-pesenti ye-omega-3s.37
Ukutya okuqhelekileyo kwaseMelika kunika umndilili we-omega-6:omega-3 umlinganiselo omalunga ne-11:1. Ukutya okusekelwe kwimifuno kunokubeka umntu emngciphekweni woku�ukutya izixa eziphakamileyo zeoyile yemifuno kunye neemveliso zesoya, kunye nezixa ezisezantsi zeentlanzi, ezinokuthi ziphelise ibhalansi ukuya kwimeko yokudumba. Ukunciphisa ioli yemifuno yokutya kunye nokwandisa i-omega-3 i-EPA kunye ne-docosahexaenoic acid (DHA) ngokutya iintlanzi ezinamafutha afana ne-cod, i-salmon, i-mackerel, kunye ne-sardines inokunceda abantu abajongene nezimo ezingapheliyo ezivuthayo.33
Izityalo ezininzi ezisetyenziselwa i-seasonings, kubandakanywa i-turmeric, i-pepper ebomvu, i-cloves, i-ginger, i-cumin, i-anise, i-fennel, i-basil, i-rosemary, i-garlic, i-pomegranate, inokuthintela i-nuclear factor-kappaB (NF?B) ukusebenza kwe-cytokines evuthayo.38
Izindlela zokutya eziguqula i-fatty acid intake zinokuchaphazela iprofayili ye-eicosanoid ngendlela yokuba iinkqubo ezivuthayo ezifana ne-arachidonic acid kunye ne-T-cell activation ziyancipha, ngelixa i-cytokines ezifana ne-interleukin-4 (i-cytokine ephambili ejongene nokuvuselela impendulo ye-immune ye-Th2. ) zilawulwa.34
Ukongezwa kweZondlo
I-Acids Fatty Acids
Amafutha abalulekileyo (EFAs) anempembelelo kwi-pathophysiology ye-psoriasis ngeendlela ezintathu: okokuqala, ii-EFA zichaphazela i-kinetics yeembrane zeseli; okwesibini, ii-EFA zichaphazela ukuhamba kwegazi kwi-dermal kunye ne-epidermal ngokuphuculwa komsebenzi we-endothelial; kwaye okwesithathu, ii-EFAs zisebenza njenge-agent ye-immunomodulating ngempembelelo yazo kwi-eicosanoids. Ii-EFAs zisetyenziswa njengeziseko ezisisiseko ekuphuhliseni i-phospholipid bi-layer phantse kuzo zonke iiseli ezisemzimbeni womntu, kubandakanya nedermis kunye ne-epidermis. Badala imfezeko yesakhiwo elawula ukuguquguquka, okuchaphazela ukuthuthwa kweeseli, ukubophelela kwezithunywa, kunye nonxibelelwano lweeseli. I-Omega-3 fatty acids inokwenza zombini ngokuthe ngqo na ngokungathanga ngqo kumsebenzi we-endothelial ngokunciphisa i-cytokines yeseli ye-mononuclear ezifana ne-IL-1 kunye ne-TNF?, I-39 iyancipha ukubunjwa kwe-chemo-ekhangayo kwiprotheni ye-platelet-derived growth factor (PDGF), ukwandisa i-bioavailability ye-nitric oxide , kunye nokunciphisa ukubonakaliswa kweemolekyuli zokubambelela. Isiphumo esongezelekayo sokumodareyitha aba balamli be-bioactive kukuthintela i-vascularization, okanye ukukhula komtya omtsha wegazi ngaphakathi kweplaque ye-psoriatic, ngelixa kwangaxeshanye ivumela ukuphuculwa kwe-perfusion ye-dermal tissue.
Izixhobo zombini zendalo kunye nokuzikhusela komzimba, kubandakanywa nokuveliswa kweemodyuli eziphambili ze-immune, kunokuchaphazeleka kwi-omega-3 kunye ne-6 fatty acid intake, njengoko kuxoxwe ngasentla. Iziphumo ze-Immunomodulatory ze-omega-3 fatty acids ziquka ukunyanzeliswa kwe-lymphoproliferation, iiseli ze-CD4 +, i-antigen presentation, i-adhesion molecule presentation, i-Th1 kunye ne-Th2 iimpendulo, kunye nokuveliswa kwe-cytokine e-pro-inflammatory.34
Izifundo ezininzi zibonise inzuzo ye-intravenous okanye yomlomo yokuncedisa ioli yeentlanzi kwi-psoriasis.40-42 Kuphando olwenziwa nguMayser et al, i-intravenous infusions ye-omega-3 fatty acids ikhokelela ekunyuseni kwe-anti-inflammatory leukotriene B5 (LTB5) phakathi kweentsuku ze-4-7 zokuqalisa unyango, xa kuthelekiswa nezigulane zokulawula. Akukho ziphumo bezingalindelekanga ziye zaqatshelwa.
I-EPA ikhuphisana ne-arachidonic acid (AA) ye-5-lipoxygenase kwaye ivelise i-LTB5, enye kuphela yeshumi njengeyona nto inamandla njenge-leukotriene B4 (LTB4) yokuvuvukala. Amanqanaba e-LTB4 abonakaliswe ukuba aphakanyiswe kwiiplagi ze-psoriatic kwaye abonise iimpawu ze-chemotactic eziyimfuneko ekungeneni kwe-leukocyte kunye ne-keratinocyte ukwanda.43
Inqaku lophononongo likaZiboh malunga ne-omega-3s kunye neereferensi ze-psoriasis izifundo ezintandathu ezenziwe kusetyenziswa isongezo se-oyile yentlanzi yomlomo eneziphumo ezixubeneyo. Ngelishwa, iireferensi zoqobo azifumaneki. Izifundo ezibini zaziyimfama kabini kwaye zilawulwa yi-placebo, zisebenzisa i-1.8 g EPA kunye ne-DHA kwiikhosi zeeveki ezisibhozo kunye neeveki ze-12. Uphononongo lweeveki ezisibhozo lubonise inzuzo kwi-itching, scaling, and erythema, ngelixa uphando lweeveki ze-12 lubonisa ukuba akukho nzuzo.44
Izifundo ezintathu ezivulekileyo zenziwe, zibonelela nge-10-18 g EPA kunye ne-DHA yonke imihla kwiiveki ezisibhozo. Zonke izifundo zibonise ukuphucuka, kunye nezifundo ezibini ezibonisa ubulali ukuya kumodareyitha kunye nophononongo olunye olubonisa ukuphucuka okuphakathi ukuya kokugqwesileyo ekunyuseni, ukurhawuzelelwa, kunye nobukhulu bezilonda. Olunye uphando oluvulekileyo oludityaniswe nokutya okunamafutha aphantsi lubonise ukunciphisa kakhulu iimpawu ze-psoriatic.44,45
Uphononongo oluninzi luphonononge ukusetyenziswa kweoyile yentlanzi esentloko kwiindawo ezahlukeneyo ze-EPA. Olunye uphando luchaze izibonelelo, kubandakanywa ukucutha ubukhulu be-plaque kunye nokulinganisa.izilonda ze-psoriatic, kunye nokunciphisa okuphawulweyo kwi-erythema.48 Eyona nto ibaluleke kakhulu i-drawback kwi-topical oil oil application kukuthotyelwa ngenxa yevumba.
Ioli yeentlanzi ibonise ukuba inenzuzo kwiimeko ezihlangeneyo ezizimeleyo ezifana ne-rheumatoid arthritis (RA) .49 Nangona ukuxhaswa kweoli yeentlanzi akuzange kusetyenziswe kwiimvavanyo zeklinikhi zonyango lwe-psoriatic arthritis, kunokuba luncedo ekuphatheni le meko, enokuthi isetyenziswe. ezininzi ezifanayo kwi-RA, kuquka indlela eqhelekileyo yokuvuvukala ephantsi kunye omzimba ukungasebenzi.
Ifayile
Unyango lwe-Methotrexate lubangela ukunqongophala kwe-folate. Njengoko kukhankanyiwe ngasentla, kwizigulane ezifumana i-MTX ye-psoriasis, i-folate supplementation yanciphisa iziganeko ze-hepatotoxicity kunye nokunyamezela kwamathumbu kodwa kunokuphazamisa ukusebenza kwe-MTX.24 Xa ukongeza i-folic acid okanye iifom ezisebenzayo, i-folinic acid okanye i-5-methyltetrahydrofolate, i-dose ephakanyisiweyo. yi-1-5 mg / ngosuku.
I-Bioactive Whey Protein Isolate
I-XP-828L iyinveli yezondlo zokutya ezenziwe ngesicatshulwa seprotheyini ephuma kwi-bovine whey esandul 'ukubonisa ukuba inenzuzo kwi-psoriasis.50,51 Iprofayili ye-bioactive ye-XP-828L inokwenzeka ngenxa yobukho bezinto zokukhula, i-immunoglobulins, kunye neepeptides ezisebenzayo ezifunyenwe kule sicatshulwa sithile se-whey. Uphononongo lwe-in vitro lubonise i-XP-828L ineempembelelo zokulawula i-immune, kubandakanywa nokuvimbela ukuveliswa kwe-cytokines ye-Th1 efana ne-IFN-g kunye ne-IL-2, enokuthi isebenze ekuphatheni izifo ezinxulumene ne-T-helper 1, ezifana ne-psoriasis. 52
Uphononongo oluvulekileyo lweleyibhile lwenziwa kwizigulane zabantu abadala be-11 abane-plaque psoriasis engapheliyo, ezinzileyo kwiipesenti ezimbini okanye ngaphezulu kwendawo yonke yomzimba. Abathathi-nxaxheba kuphononongo bafumana i-5 g kabini imihla ngemihla ye-XP-828L kwiintsuku ezingama-56. Uvavanyo olusebenzisa iPASI kunye neGlobal Assessment (PGA) amanqaku enziwe ngosuku lokuqala lokuhlola kwaye kwakhona ngeentsuku ze-1, i-28, kunye ne-56. Ekupheleni kophando, izifundo ezisixhenxe ze-11 zinezinga elincitshisiweyo le-PASI eliphakathi. ukusuka kwi-9.5 ukuya kwi-81.3 yeepesenti. 50 Iziphumo ze-double-blind enkulu,Uphononongo olulawulwa yi-placebo lwabantu be-84 abane-psoriasis e-mildto-moderate babonisa i-XP-828L (i-5 g / imini yeentsuku ze-56) yanciphisa kakhulu amanqaku e-PGA xa kuthelekiswa ne-placebo (p <0.05). Akukho zimpembelelo ezimbi eziye zaqatshelwa kuzo naziphi na abathathi-nxaxheba bophando kuyo nayiphi na isifundo.50,51
Vitamin D
Kuye kwaqinisekiswa ukuba izigulane ezine-psoriasis ezisasazwayo ziye zanciphisa kakhulu amanqanaba e-serum yefom ye-biologically esebenzayo ye-vitamin D, i-1-alpha, i-25-dihydroxyvitamin D3 (1-?, 25 (OH) 2D3; i-calcitriol) xa kuthelekiswa nobudala kunye nesondo. Ukulawulwa okuhambelanayo kunye nokuthelekiswa nezigulane ezine-psoriasis ephakathi.53 Ingaba le nto inegalelo kwi-psoriasis okanye umphumo we-disorder awukacaciswanga.
I-Keratinocytes kwi-epidermis iguqula i-7-dehydrocholesterol kwi-vitamin D3 phambi kwe-UVB. Ukukhanya kwelanga, i-UVB phototherapy, i-calcitriol yomlomo, kunye ne-topical vitamin D analogs lunyango olusebenzayo lwe-psoriasis ngenxa ye-vitamin D ye-anti-proliferative kunye ne-pro-differentiating action kwi-keratinocytes.54-56
I-Calcitriol-ibophelela kwi-vitamin D receptors (VDR) elukhumbeni imodareyitha ukubonakaliswa kwenani elikhulu leejeni ezibandakanya abalawuli be-cell cycle, izinto zokukhula, kunye nabamkeli babo. Iipolymorphisms ze-VDR gene zidibene ne-psoriasis kwaye zinokuthi zilungele ukuphuhliswa kwe-psoriasis kunye nokuchasana nonyango lwe-calcipotriol, kunye negalelo ekungasebenzi kakuhle kwesibindi kwizigulane ezine-psoriasis.57
Ngenxa yokubaluleka kwe-vitamin D kwi-psoriasis, umhlaza, izifo ezivuthayo, kunye nezinye iimeko, kuye kwacetyiswa ngabaphandi ukuba iingcebiso zokukhuselwa kwelanga kunye nokukhusela umhlaza wolusu kunokufuneka ukuba zihlolwe kwakhona ukuze zivumele isimo esaneleyo se-vitamin D. Uphononongo olutshanje lubonise ubuninzi belanga kwisampulu yabantu abadala baseHawaii abazange baqinisekise ukwanela kwe-vitamin D, ebonisa isidingo sokuxhaswa kwe-vitamin D ukufezekisa amanqanaba aphezulu egazi.58
Uphononongo lubonise ukuba i-vitamin D yomlomo inokuthatyathwa ngokukhuselekileyo kwiidosi zemihla ngemihla ukuya kwi-5,000 IU, ezinye iingcali zincoma ukuya kwi-10,000 IU imihla ngemihla ukulungisa ukusilela.59-61 I-Oral kunye ne-topical vitamin D, ukukhanya kwelanga kunye ne-UVB phototherapy ibonise ukusebenza kakuhle kunyango lwe-psoriasis.56
Imixholo yoNyango lwePsoriasis
Unyango oluninzi lwe-psoriasis lunokubonelela ngenzuzo, kuquka i-calcipotriene (iDovonex�; i-analogue ye-vitamin D3 yokwenziwa), i-Berberis aquifolium cream (10%) 62 (Psoriaflora�; Relieva�), i-curcumin gel (1%), i-Aloe vera, kunye ne-aloe vera. isalve etyebileyo yeflavonoid (Flavsalve�).
Ijeli ye-Curcumin yanikezela isisombululo se-90-pesenti yeeplagi kwiipesenti ze-50 zezigulane kwiiveki ze-2-6; intsalela yezifundo zophononongo ibonise i-50- kwi-85-ipesenti yokuphucula. I-Curcumin yafunyanwa iphindwe kabini njenge-calcipotriol cream (ehlala ithatha iinyanga ezintathu ukwenza umphumo wayo opheleleyo). Indlela ye-curcumin injenge-phosphorylase kinase inhibitor ekhethiweyo, ngaloo ndlela inciphisa ukuvuvukala ngokuvinjelwa kwe-NF?B.63
Uvavanyo olulawulwayo lwe-Aloe vera extract cream (0.5%) kwizigulane ze-60 kwiinyanga ezi-4-12 zibonise ukucocwa okuphawulekayo kwamacwecwe e-psoriatic (82.8%) xa kuthelekiswa ne-placebo (7.7%) (p<0.001). Ukongezelela, i-PASI iyancipha ibe yintsingiselo ye-2.2.64
Ubukhulu be-psoriasis buxhamla ekusebenziseni i-emollients. I-lipids ye-intercellular efana ne-ceramides (i-lipid molecules ezenziwe ngamafutha acids kunye ne-sphingosine) zidlala indima ebalulekileyo ekulawuleni i-homeostasis yesithintelo samanzi kunye nomthamo wamanzi. Kuye kwaboniswa ukuba i-ceramide iyancipha kwi-epidermis ye-psoriatic. I-emollients entsha equkethe i-ceramide (umzekelo, i-CeraVe�, i-Mimyx�, i-Aveeno Eczema Care) ibonise inzuzo kwi-psoriasis kwaye inokuphucula umsebenzi wokuthintela ulusu kunye nokunciphisa ukulahlekelwa kwamanzi.65
Iimpembelelo zeBotanical
I-Chinese herbal formula (Herose� Psoria Capsule) ibonise ukhuseleko kunye nokusebenza kakuhle kunyango lwe-plaque psoriasis enzima.66 I-Herose iqukethe i-rhizoma Zingiberis, i-radix Salviae miltiorrhizae, i-radix Astragali, i-ramulus Cinnamomi, i-radix Paeoniae alba, i-radix Codonopsis pilosula. Coicis. Kwilingo le-openlabel, izifundo ze-15 zathatha ii-capsules ezine ze-Herose (450 mg nganye) kathathu imihla ngemihla kwiinyanga ze-10. Umphandi uvavanye iPASI kunye nempendulo yonyango kwiHerose kwisigulane ngasinye. Ifomula yenzelwe ukufudumala i-yang kunye nokukhuthaza ukujikeleza kwegazi.
Ukungenelela kwindlela yokuphila
Izinto zokuphila ezifana nokutshaya icuba kunye nokusela utywala zihambelana nobunzima be-psoriasis.67 Umsebenzi owenziwe ngokomzimba kunye nemisebenzi yangaphandle (ukuthatha izilumkiso zokutshisa ilanga) kunenzuzo.68 Ukuhlamba kunye nokutshisa ilanga kuLwandle Olufileyo kwiiveki ezine kubangele ukuhla kwePASI ye Ipesenti ze-81.5, i-78-pesenti iyancipha kwi-keratinocyte hyperplasia, kwaye phantse ukupheliswa ngokupheleleyo kwe-T lymphocytes kwi-epidermis, kunye nenani eliphantsi eliseleyo kwi-dermis.69
Ulawulo loxinzelelo lunokunceda abantu abane-psoriasis. Izifundo eziphulaphule i-tape yokucamngca ekhokelwayo ngelixa i-phototherapy ihlanjululwa ngokuphindwe kane ngokukhawuleza kunabo bafumana i-phototherapy kuphela, njengoko kugwetywa ngabadermatologists ababini abazimeleyo. Isimo se-Psoriasis savavanywa ngeendlela ezintathu: ukuhlolwa ngokuthe ngqo ngabahlengikazi bekliniki; ukuhlolwa ngokuthe ngqo ngoogqirha abamfamekileyo kwimeko yokufunda yesigulana (iteyiphu okanye akukho tape); kunye novavanyo logqirha olumfamekileyo lweefoto zezilonda ze-psoriasis. Iimpawu ezine ezilandelelanayo zesimo solusu zibekwe iliso ngexesha lokufunda: iNdawo yokuPhendula yokuQala, iNdawo yokuTshintsha, iHalfway Point, kunye neClearing Point. Izifundo kumaqela e-tape zifikelele kwi-Halfway Point (p = 0.013) kunye ne-Clearing Point (p = 0.033) ngokukhawuleza kakhulu kunezo zingekho kwimeko ye-tape, kuzo zombini unyango lwe-UVB kunye ne-PUVA.70 Ekugqibeleni, i-psychotherapy ingaba yinto ebalulekileyo. iadjunct kubantu abanemiba yengqondo ethe gqolo engasonjululwanga enje ngoxinzelelo, uxinzelelo, kunye noxinzelelo lwengqondo kwesi sifo solusu singapheliyo.
ingxoxo
I-Psoriasis ibonakaliswe yi-T-cell activation ekhupha i-cytokines e-pro-inflammatory efana ne-TNF-?, ekhokelela ekwandeni kwe-keratinocyte kunye nezilonda zesikhumba eziqhelekileyo ze-psoriasis.
Indlela yesiqhelo yokunyanga i-psoriasis ibandakanya ukusebenzisa i-topical kunye/okanye i-corticosteroids yomlomo, amanye amachiza akhusela umzimba, i-retinoids yomlomo, ukukhanya kwe-UV, kunye nezininzi (ezingeyiyo inoveli, esele isetyenziswe ngaphambili kwi-Crohn's kunye ne-RA) i-biological agents. Nangona olu nyango lunokusebenza kakhulu ekulawuleni isifo, alukho olukhuselekileyo nolusebenzayo jikelele, kwaye ngalinye linomngcipheko omkhulu.
Kukho ubungqina bokusetyenziswa kokuguqulwa kokutya kunye neoli yeentlanzi ukunciphisa ukuvuvukala kwi-psoriasis. Uphando olongezelelekileyo lugunyaziswe ukucacisa ukusetyenziswa�kwezi kunye neendlela ezahlukeneyo zonyango lwebhotani kunye neendlela zokuphila zokuphucula iimpawu zeklinikhi, ukunciphisa ukubonakaliswa kwe-phenotypic ye-psoriasis, kunye nokubonelela ngonyango olukhuselekileyo nolusebenzayo.